Molecularly guided precision therapy in metastatic adamantinoma: a case report [0.03%]
分子导向的精准治疗腺瘤样鳞癌肝转移一例报告
Aram A Musaelyan,Svetlana V Odintsova,Alexander O Ivantsov et al.
Aram A Musaelyan et al.
Adamantinoma is a rare bone tumor characterized by a propensity for local recurrence and distant metastasis. Management of metastatic disease remains challenging owing to the absence of standardized therapy and the limited efficacy of conve...
Study of association between rs72703442 and rs55683539 genetic variants in MIR31HG and the risk of breast cancer [0.03%]
MIR31HG基因rs72703442和rs55683539遗传变异与乳腺癌风险的相关性研究
Omar Jamal Khalaf Al-Nasani,Somayeh Reiisi
Omar Jamal Khalaf Al-Nasani
Background: Genetic variations in non-coding RNAs, including MIR31HG, which hosts microRNA-31, have been linked to breast cancer (BC) susceptibility. Current study aimed to evaluate the correlation between two MIR31HG var...
Evaluating the impact of infectious disease pharmacy services on voriconazole dose individualization in pediatric oncology [0.03%]
评估传染病药学服务对儿科肿瘤学伏立康唑剂量个体化的影响
Mai Samy Azab,Dalia Makhlouf,Omneya Ahmed et al.
Mai Samy Azab et al.
Background: The application of personalized medication management for Voriconazole(VCZ), such as therapeutic drug monitoring (TDM), is the gold standard for attaining therapeutic goals in invasive fungal infections. Infec...
Maria Cristina Sini,Milena Casula,Marina Pisano et al.
Maria Cristina Sini et al.
Melanoma is a malignant tumour arising from melanocytes and is the most aggressive type of skin cancer. In advanced disease standard treatments are largely ineffective. About 40% of cutaneous melanomas carry BRAF mutations-more common in yo...
A multilevel ensemble model for predicting mutation types in bladder cancer [0.03%]
一种预测膀胱癌突变类型的多级ensembl模型
Aneesh Jain,Sumit Dey,Divisha Garg et al.
Aneesh Jain et al.
Background: In urinary bladder cancer, early diagnosis plays a key role for effective patient management. Moreover, accurate prediction of genetic mutations plays a critical role in identifying biomarkers for prognosis an...
MYC variant at 8q24 increases susceptibility to urinary bladder cancer: a meta-analysis of 53,957 individuals [0.03%]
8q24处的MYC变异通过 meta分析发现其增加了53957名个体患膀胱癌的风险
Francisco Cezar Aquino de Moraes,Luis Henrique Rios Moreira Rego,Victória Morbach et al.
Francisco Cezar Aquino de Moraes et al.
Background: Urinary bladder cancer (UBC), the tenth most common globally with a male predominance, has its risk factors like smoking and single nucleotide polymorphisms (SNPs), yet the MYC gene's role, especially the rs96...
Correction [0.03%]
改正通知书
Published Erratum
Personalized medicine. 2025 Nov 18:1. DOI:10.1080/17410541.2025.2589677 2025
Polygenic risk scores to refine Breast cancer screening and prevention strategies [0.03%]
多基因风险评分在乳腺癌筛查和预防策略中的应用
E Roberts,N Flaum,S J Howell et al.
E Roberts et al.
Breast cancer (BC) is the world's most prevalent cancer and can affect almost any post-pubertal woman. Early detection is associated with improved survival, and most high-income countries have adopted population-based screening programs to ...
Leveraging oncology clinical case report data through the Cancer Knowledgebase (CKB) [0.03%]
通过癌症知识库(CKB)利用肿瘤临床病例报告数据
Rewatee H Gokhale,Cara M Statz,Taofei Yin et al.
Rewatee H Gokhale et al.
Aims: Clinical case reports in oncology are an untapped resource of patient data that include relationships between molecular alterations, tumor types, and response to targeted therapy. A current challenge to widespread u...
Patient-Derived Tumour Organoids (PDOs) may help oncologists in clinical practice [0.03%]
患者来源的肿瘤类器官(PDOs)可能有助于临床实践中的肿瘤学家
Renata Brandi,Alina Catalina Palcau,Emilia Migliano et al.
Renata Brandi et al.
The use of cancer organoids represents a major advancement in oncology research, addressing the limitations of traditional 2D cell cultures. Optimized protocols now allow the generation of organoids from a wide range of tumor types, includi...